ArticleNucleic acids research2025
Mechanism of deamination by mycobacterial deaminase selectively targeting mutagenic bases.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Nucleobase deaminases are important players in maintaining a stringent nucleobase pool and enhancing genetic diversity via judicious base editing. Here, we delineate the mechanism of Mycobacterium smegmatis deaminase, Msd, found predominantly in Mycobacterium species, that selectively catalyzes the deamination of mutagenic bases. Molecular dynamic studies reveal the dynamic nature of unique structural insertions that cycle between 'closed' and 'open' states, enabling zinc-assisted deamination by occluding the solvent. Corroborating X-ray crystallographic and biochemical studies assert that the appropriate length of the two gating loops and proper positioning of the di-proline motif they harbor are paramount to effective closure. Analysis reveals that although both natural base deaminases, guanine and cytosine deaminase, operate via a similar gating mechanism to Msd, they employ topologically differentially placed structural elements to achieve the 'closed' form. The comparison shows that Mycobacterium deaminases lack the dual-proton shuttle, which renders them ineffective for the deamination of natural bases but allows them to selectively target mutagenic s-triazine scaffolds, thereby imparting innate immunity against these drugs. The study highlights how topologically unique insertions in the cytidine deaminase fold play a critical role in harnessing evolutionary versatility, responsible in imparting fidelity for a nucleobase deamination reaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.